| Literature DB >> 25982825 |
Brittany Butts1, Rebecca A Gary1, Sandra B Dunbar1, Javed Butler2.
Abstract
Patients with heart failure continue to suffer adverse health consequences despite advances in therapies over the past 2 decades. Identification of novel therapeutic targets that may attenuate disease progression is therefore needed. The inflammasome may play a central role in modulating chronic inflammation and in turn affecting heart failure progression. The inflammasome is a complex of intracellular interaction proteins that trigger maturation of proinflammatory cytokines interleukin-1β and interleukin-18 to initiate the inflammatory response. This response is amplified through production of tumor necrosis factor α and activation of inducible nitric oxide synthase. The purpose of this review is to discuss recent evidence implicating this inflammatory pathway in the pathophysiology of heart failure.Entities:
Keywords: Heart failure; inflammasome; inflammation
Mesh:
Substances:
Year: 2015 PMID: 25982825 PMCID: PMC4516025 DOI: 10.1016/j.cardfail.2015.04.014
Source DB: PubMed Journal: J Card Fail ISSN: 1071-9164 Impact factor: 5.712